Fox Run Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $989K | Buy |
35,743
+24,391
| +215% | +$675K | 0.16% | 196 |
|
|
2025
Q1 | $252K | Buy |
+11,352
| New | +$252K | 0.04% | 731 |
|
|
2024
Q4 | – | Sell |
-9,723
| Closed | -$243K | – | 1030 |
|
|
2024
Q3 | $243K | Buy |
+9,723
| New | +$243K | 0.05% | 617 |
|
|
2024
Q1 | – | Sell |
-12,546
| Closed | -$220K | – | 932 |
|
|
2023
Q4 | $220K | Buy |
+12,546
| New | +$220K | 0.06% | 609 |
|
|
2023
Q2 | – | Sell |
-15,221
| Closed | -$164K | – | 828 |
|
|
2023
Q1 | $164K | Buy |
+15,221
| New | +$164K | 0.05% | 561 |
|